HR 5122
114th Congress
House
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Drug therapy
Medicare
Prescription drugs
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Introduced: April 29, 2016
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 12, 2016
Referred to the Subcommittee on Health.
May 6, 2016
Referred to the Subcommittee on Health.
Apr 29, 2016
Introduced in House
Apr 29, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Plain-English summary
This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4